News
3 hours ago
Front Porch announces Brain and Balance Center in Carlsbad, California
Clinical Result
3 hours ago
Bartow Regional Medical Center Groundbreaking Signals Beginning of Expansion
3 hours ago
Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results
Phase 2Financial StatementExecutive ChangeClinical Result
4 hours ago
Relmada Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Phase 2Financial StatementPhase 1Phase 3
4 hours ago
Nektar Therapeutics Reports Third Quarter 2024 Financial Results
Phase 2Phase 1Clinical ResultImmunotherapyASH
4 hours ago
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter and Year to Date 2024 Financial Results on November 14, 2024
Financial StatementBreakthrough TherapyFast Track
4 hours ago
HotSpot Therapeutics Presents Additional Phase 1 Biomarker Data on Novel CBL-B Inhibitor HST-1011 at 2024 Society for Immunotherapy of Cancer Annual Meeting
Phase 1ImmunotherapyAACR
4 hours ago
Spyre Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Phase 1Executive ChangeFinancial StatementPhase 3Phase 2
4 hours ago
Tyra Biosciences Reports Third Quarter 2024 Financial Results and Highlights
Phase 1Phase 2Clinical ResultINDExecutive Change
4 hours ago
Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates
Phase 1Financial StatementClinical ResultLicense out/in